Exploring heterogeneity in mild cognitive impairment.

IF 3.4 3区 医学 Q2 NEUROSCIENCES
Journal of Alzheimer's Disease Pub Date : 2024-11-01 Epub Date: 2024-11-10 DOI:10.1177/13872877241290127
Zachary T Goodman, Maria M Llabre, Sonya Kaur, Nikhil Banerjee, Katalina McInerney, Xiaoyan Sun, Anita Seixas Dias Saporta, Bonnie E Levin
{"title":"Exploring heterogeneity in mild cognitive impairment.","authors":"Zachary T Goodman, Maria M Llabre, Sonya Kaur, Nikhil Banerjee, Katalina McInerney, Xiaoyan Sun, Anita Seixas Dias Saporta, Bonnie E Levin","doi":"10.1177/13872877241290127","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Mild cognitive impairment (MCI) is a heterogeneous diagnostic entity, without a clear prognosis, often accompanied by psychiatric symptomatology and physical frailty.</p><p><strong>Objective: </strong>Understanding the heterogeneity within MCI is a critical step in improving the early detection of cognitive decline and developing effective interventions.</p><p><strong>Methods: </strong>Cross-sectional multivariate latent mixture analyses of data from patients evaluated between 2015 and 2019, who were routinely entered into a multidisciplinary database for research purposes. A sample of 538 community-dwelling older adults drawn from a large academic medical center, referred from within the Department of Neurology (63.7% Female, <i>M</i><sub>age </sub>= 67.8, <i>SD</i><sub>age </sub>= 10.6). Participants completed comprehensive neuropsychological assessments, psychiatric symptom measures, and frailty evaluations.</p><p><strong>Results: </strong>Latent profile analyses supported five profiles of cognitive impairment: <i>At-Risk</i>, <i>Pre-MCI</i>, <i>Amnestic MCI</i>, <i>Multiple Domain MCI</i>, and <i>Major Cognitive Impairment</i>. The inclusion of concomitant psychiatric symptoms and frailty criteria revealed two additional profiles: <i>Psychiatric/Frail</i>, without cognitive impairments, and <i>Multiple Cognitive Domains/Psychiatric/Frail</i>. Critically, 55% of those classified as <i>Healthy</i> based on cognitive data alone were reclassified. Significant profile-wise differences emerged across auxiliary variables of brief cognitive screening, sociodemographics, and medical and psychosocial risk.</p><p><strong>Conclusions: </strong>Results highlight heterogeneity represented by neurologic patients referred for neuropsychological evaluation that include key physical and emotional symptoms known to increase the risk of cognitive decline. Findings are in alignment with more recent research suggesting that the traditional paradigm cognitive impairment may need to be expanded to improve diagnostic accuracy and to develop more tailored, precision-driven interventions.</p>","PeriodicalId":14929,"journal":{"name":"Journal of Alzheimer's Disease","volume":" ","pages":"411-423"},"PeriodicalIF":3.4000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Alzheimer's Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/13872877241290127","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/10 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Mild cognitive impairment (MCI) is a heterogeneous diagnostic entity, without a clear prognosis, often accompanied by psychiatric symptomatology and physical frailty.

Objective: Understanding the heterogeneity within MCI is a critical step in improving the early detection of cognitive decline and developing effective interventions.

Methods: Cross-sectional multivariate latent mixture analyses of data from patients evaluated between 2015 and 2019, who were routinely entered into a multidisciplinary database for research purposes. A sample of 538 community-dwelling older adults drawn from a large academic medical center, referred from within the Department of Neurology (63.7% Female, Mage = 67.8, SDage = 10.6). Participants completed comprehensive neuropsychological assessments, psychiatric symptom measures, and frailty evaluations.

Results: Latent profile analyses supported five profiles of cognitive impairment: At-Risk, Pre-MCI, Amnestic MCI, Multiple Domain MCI, and Major Cognitive Impairment. The inclusion of concomitant psychiatric symptoms and frailty criteria revealed two additional profiles: Psychiatric/Frail, without cognitive impairments, and Multiple Cognitive Domains/Psychiatric/Frail. Critically, 55% of those classified as Healthy based on cognitive data alone were reclassified. Significant profile-wise differences emerged across auxiliary variables of brief cognitive screening, sociodemographics, and medical and psychosocial risk.

Conclusions: Results highlight heterogeneity represented by neurologic patients referred for neuropsychological evaluation that include key physical and emotional symptoms known to increase the risk of cognitive decline. Findings are in alignment with more recent research suggesting that the traditional paradigm cognitive impairment may need to be expanded to improve diagnostic accuracy and to develop more tailored, precision-driven interventions.

探索轻度认知障碍的异质性。
背景:轻度认知障碍(MCI)是一种异质性诊断实体,没有明确的预后:轻度认知障碍(MCI)是一种异质性诊断实体,没有明确的预后,通常伴有精神症状和身体虚弱:目的:了解 MCI 的异质性是改善认知功能衰退早期检测和制定有效干预措施的关键一步:对2015年至2019年期间接受评估的患者数据进行横断面多变量潜在混合物分析,这些患者因研究目的被例行输入多学科数据库。样本中的538名社区居住老年人来自一家大型学术医疗中心,由神经内科转介(63.7%为女性,年龄=67.8,平均年龄=10.6)。参与者完成了全面的神经心理评估、精神症状测量和虚弱评估:结果:潜在特征分析支持五种认知障碍特征:结果:潜特征分析支持五种认知损害特征:濒危、MCI 前、失忆型 MCI、多领域 MCI 和主要认知损害。将同时出现的精神症状和虚弱标准纳入后,又发现了另外两种情况:无认知障碍的精神病患者/体弱者和多认知领域/精神病患者/体弱者。重要的是,55% 仅根据认知数据被归类为 "健康 "的患者被重新归类。在简短认知筛查、社会人口学、医疗和社会心理风险等辅助变量之间出现了显著的特征差异:研究结果凸显了转诊进行神经心理评估的神经科患者的异质性,其中包括已知会增加认知能力下降风险的主要身体和情绪症状。研究结果与最近的研究结果一致,这些研究结果表明,可能需要扩大认知障碍的传统范式,以提高诊断的准确性,并开发更多量身定制的精准干预措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Alzheimer's Disease
Journal of Alzheimer's Disease 医学-神经科学
CiteScore
6.40
自引率
7.50%
发文量
1327
审稿时长
2 months
期刊介绍: The Journal of Alzheimer''s Disease (JAD) is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer''s disease. The journal publishes research reports, reviews, short communications, hypotheses, ethics reviews, book reviews, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer''s disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信